663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials - Shorr, Andrew F; Schranz, Jennifer; Goldberg, Lisa; Paukner, Susanne; Das, Anita F; Moran, Gregory J; Sandrock, Christian; File, Thomas M; Alexander, Elizabeth; Gelone, Steven P (Open Forum Infectious Diseases, 2019)